UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 269

Sortiert nach

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Endocrine reviews, 2012-12, Vol.33 (6), p.981-1030

2012

Link zum Volltext

Verfügbarkeit prüfen

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

Fertility and sterility, 2009-02, Vol.91 (2), p.456-488

2009

Link zum Volltext

Verfügbarkeit prüfen

Polycystic Ovary Syndrome: Challenging Issues in the Modern Era of Individualized Medicine

Diamanti-Kandarakis, Evanthia

1, 2021

Link zum Volltext

Verfügbarkeit prüfen

Polycystic ovary syndrome and environmental toxins

Fertility and sterility, 2016-09, Vol.106 (4), p.948-958

2016

Link zum Volltext

Verfügbarkeit prüfen

Environmental Endocrinology and Endocrine Disruptors: Endocrine and Endocrine-Targeted Actions and Related Human Diseases

1, 2023

Link zum Volltext

Verfügbarkeit prüfen

Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue

Journal of cellular and molecular medicine, 2010-10, Vol.14 (10), p.2460-2469

2010

Link zum Volltext

Verfügbarkeit prüfen

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

European journal of endocrinology, 2014-10, Vol.171 (4), p.P1

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome

Clinical endocrinology (Oxford), 2007-01, Vol.66 (1), p.103-109

2007

Link zum Volltext

Verfügbarkeit prüfen

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS

Clinical endocrinology (Oxford), 2007-11, Vol.67 (5), p.735-742

2007

Link zum Volltext

Verfügbarkeit prüfen

Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement

Endocrine reviews, 2009-06, Vol.30 (4), p.293-342

2009

Link zum Volltext

Verfügbarkeit prüfen

Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease

Frontiers in endocrinology (Lausanne), 2019-03, Vol.10, p.112-112

2019

Link zum Volltext

Verfügbarkeit prüfen

Oxidative Stress in Polycystic Ovary Syndrome

Current pharmaceutical design, 2016-01, Vol.22 (18), p.2709

2016

Link zum Volltext

Verfügbarkeit prüfen

Crosstalk between Advanced Glycation and Endoplasmic Reticulum Stress: Emerging Therapeutic Targeting for Metabolic Diseases

The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.2231-2242

2012

Link zum Volltext

Verfügbarkeit prüfen

Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)

Reviews in endocrine & metabolic disorders, 2015-12, Vol.16 (4), p.365-371

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

Trends in molecular medicine, 2006-07, Vol.12 (7), p.324-332

2006

Link zum Volltext

Verfügbarkeit prüfen

Phenotypes and enviromental factors: their influence in PCOS

Current pharmaceutical design, 2012, Vol.18 (3), p.270

2012

Link zum Volltext

Verfügbarkeit prüfen

Metformin in polycystic ovary syndrome

Annals of the New York Academy of Sciences, 2010-09, Vol.1205 (1), p.192-198

2010

Link zum Volltext

Verfügbarkeit prüfen

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

European journal of endocrinology, 2010-02, Vol.162 (2), p.193

2010

Link zum Volltext

Verfügbarkeit prüfen

The effects of old, new and emerging medicines on metabolic aberrations in PCOS

Therapeutic advances in endocrinology and metabolism, 2012-02, Vol.3 (1), p.27-47

2012

Link zum Volltext

Verfügbarkeit prüfen

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

The journal of clinical endocrinology and metabolism, 2006-11, Vol.91 (11), p.4237-4245

2006

Link zum Volltext

Verfügbarkeit prüfen

Advanced glycation end-products and insulin signaling in granulosa cells

Experimental biology and medicine (Maywood, N.J.), 2016-07, Vol.241 (13), p.1438-1445

2016

Link zum Volltext

Verfügbarkeit prüfen

Is cardiovascular risk in women with PCOS a real risk? Current insights

Minerva endocrinologica, 2017-12, Vol.42 (4), p.340

2017

Link zum Volltext

Verfügbarkeit prüfen

Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?

Current pharmaceutical design, 2016-01, Vol.22 (36), p.5558

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

Clinical endocrinology (Oxford), 2008-10, Vol.69 (4), p.634-641

2008

Link zum Volltext

Verfügbarkeit prüfen

Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review

Frontiers in endocrinology (Lausanne), 2019-06, Vol.10, p.388-388

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(228)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Life Sciences & Biomedicine
(173)
Humans
(139)
Female
(129)
Endocrinology & Metabolism
(111)
Endocrinology
(77)
Adult
(65)
Polycystic Ovary Syndrome
(56)
Insulin Resistance
(55)
Biological And Medical Sciences
(53)
Medical Sciences
(51)
Diabetes
(49)
Polycystic Ovary Syndrome - Blood
(37)
Clinical & Internal Medicine
(35)
Gynecology. Andrology. Obstetrics
(35)
Obstetrics & Gynecology
(31)
Polycystic Ovary Syndrome - Physiopathology
(31)
Polycystic Ovary Syndrome - Metabolism
(30)
Adolescent
(29)
Pcos
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

Polycystic Ovary Syndrome: Challenging Issues in the Modern Era of Individualized Medicine

Polycystic ovary syndrome and environmental toxins

Environmental Endocrinology and Endocrine Disruptors: Endocrine and Endocrine-Targeted Actions and Related Human Diseases

Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS

Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement

Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease

Oxidative Stress in Polycystic Ovary Syndrome

Crosstalk between Advanced Glycation and Endoplasmic Reticulum Stress: Emerging Therapeutic Targeting for Metabolic Diseases

Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

Phenotypes and enviromental factors: their influence in PCOS

Metformin in polycystic ovary syndrome

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

The effects of old, new and emerging medicines on metabolic aberrations in PCOS

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Advanced glycation end-products and insulin signaling in granulosa cells

Is cardiovascular risk in women with PCOS a real risk? Current insights

Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?

Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review

Suchergebnisse filtern